Peptron
Daejeon, KR · 1 known investors
Peptron is a Korean pharmaceutical company that develops sustained-release injectable drug formulations using its proprietary SmartDepot ultrasonic spray drying technology to create long-acting microsphere formulations. It operates a GMP-designed manufacturing facility producing SR-exenatide and is developing exenatide as a treatment for neurodegenerative disorders under licensed NIH patents.
Investors · 1
Competitors · 2
by search overlap
Superpower7 shared keywordsSuperpower offers personalized health testing and monitoring for consumers, analyzing 100+ biomarkers across multiple body systems. The platform combines blood testing, data integration from wearables, AI-powered analysis, and access to clinical care teams to provide personalized health protocols and longevity guidance.
Health Unlocked7 shared keywordsHealthUnlocked is a social network for health where users connect with others managing similar health conditions and access support resources, e-learning, and expert guidance across over 300 health conditions and wellness interests.
Companies competing with Peptron for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Peptron do?
- Peptron is a Korean pharmaceutical company that develops sustained-release injectable drug formulations using its proprietary SmartDepot ultrasonic spray drying technology to create long-acting microsphere formulations. It operates a GMP-designed manufacturing facility producing SR-exenatide and is developing exenatide as a treatment for neurodegenerative disorders under licensed NIH patents.
- Who are Peptron's investors?
- Peptron's investors include Agate Medical Investments LP.
- Where is Peptron headquartered?
- Peptron is headquartered in Daejeon, KR.